Skip to content

A Call Center During HAE Attacks (SOS HAE)

Hereditary Angioedema : Interest From the Use of a Call Center During the Attacks.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01679912
Acronym
SOS AOH
Enrollment
200
Registered
2012-09-06
Start date
2013-03-31
Completion date
2016-09-30
Last updated
2016-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary Angioedema

Keywords

Hereditary angioedema, Emergency Medical Service, Health care coast, Telephone

Brief summary

This clinical trial aims to compare morbidity and cost associated with acute attacks of hereditary angioedema in patients with an intervention based on a support after a phone call to the call center (SOS HAE) from a group of patients does not change their practice.

Detailed description

Investigators propose a study to determine whether a call center for an acute attack of HAE associated with intervention recommendations based on systematic early treatment (self-administration at home or by a caregiver) would reduce the morbidity and the socioeconomic impact.

Interventions

OTHERphone to the call center

recommendations to phone to the call center for all the patients who have an acute attack

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with an hereditary angioedema followed in a reference center for bradykinin angioedema (CRéAk) * Patient's age ≥ 18 years * Consent to the participation in the study * Affiliated to social security

Exclusion criteria

* pregnant woman * recent history of myocardial infarction * recent history of stroke * allergy to icatibant or C1 inhibitor concentrate

Design outcomes

Primary

MeasureTime frame
Number of hospital admissions for angioedema attack- no (%)at 2 years

Secondary

MeasureTime frame
Number of ED admissions - no (%)at 2 years
Number of hospital admissions for others causes - no (%)at 2 years
Number of intubations - no (%)at 2 years
Number of EMS interventions - no (%)at 2 years
Number of ICU admissions - no (%)at 2 years
Mortality - no (%)at 2 years
Mortality for angioedema attack- no (%)at 2 years
Cost of angioedema attacksat 2 years
Number of working days lostat 2 years

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026